Call UsCall Us :
200 mg Avelumab Injection

200 mg Avelumab Injection

Product Details:

X

Product Description

We are a trusted name among the manufacturers of 200 mg Avelumab Injection in the market. It is indicated for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC). 200 mg Avelumab Injection is approved under accelerated approval based on tumor response rate and duration of response.


RAVI WORLDWIDE MEDICINES PRIVATE LIMITED

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.